Can chemotherapy cause infertility in men?

Chemotherapy can indeed cause infertility in men, primarily because it damages the cells responsible for producing sperm. The drugs used in chemotherapy target rapidly dividing cells to kill cancer, but unfortunately, this includes healthy sperm-producing cells in the testes. This damage can lead to a reduced sperm count, poor sperm quality, or even complete absence of sperm, resulting in infertility.

The extent to which chemotherapy affects male fertility depends on several factors. One of the most important is the type of chemotherapy drugs used. Alkylating agents, such as cyclophosphamide and procarbazine, are particularly harmful to sperm production because they cause DNA damage in the cells that divide rapidly, including sperm precursor cells. Other chemotherapy drugs may be less toxic to sperm but can still contribute to fertility problems, especially when combined with alkylating agents or other treatments.

The dosage and duration of chemotherapy also play a critical role. Higher doses and longer treatment periods increase the risk of permanent damage to sperm-producing cells. Additionally, the age of the patient matters; younger men, especially those who have not yet reached puberty, may be more vulnerable to the effects of chemotherapy on fertility. The location of radiation therapy, if combined with chemotherapy, can further impact fertility, especially if the testes or nearby areas are exposed.

Chemotherapy’s impact on fertility can be temporary or permanent. In some men, sperm production may recover months or years after treatment ends, but in others, the damage is irreversible. This variability depends on the individual’s biology, the specific treatment regimen, and other health factors.

Beyond sperm production, chemotherapy can also affect hormone levels that regulate fertility. Damage to the testes or the pituitary gland (which controls hormone secretion) can lead to hormonal imbalances, affecting libido, erectile function, and the ability to produce viable sperm.

Because of these risks, men who are about to undergo chemotherapy are often advised to consider fertility preservation options before treatment begins. The most common method is sperm banking, where sperm samples are collected and frozen for future use. This allows men the possibility of fathering biological children even if chemotherapy causes permanent infertility.

Other fertility preservation techniques are being researched and developed, but sperm banking remains the most established and accessible option for men facing chemotherapy.

In summary, chemotherapy can cause infertility in men by damaging sperm-producing cells and affecting hormone regulation. The risk depends on the type and dose of chemotherapy drugs, the patient’s age, and whether radiation therapy is also involved. Fertility preservation strategies like sperm banking are important considerations before starting treatment to safeguard future reproductive options.